CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seven Bridges, the biomedical data analysis company, today announced several upcoming speaking engagements where CEO Deniz Kural and scientific program manager Brandi Davis-Dusenbery will discuss new developments in precision medicine and cancer research informatics.
